Page last updated: 2024-10-30

mecamylamine and Liver Cirrhosis

mecamylamine has been researched along with Liver Cirrhosis in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research Excerpts

ExcerptRelevanceReference
"Cigarette smoke (CS) may cause liver fibrosis but possible involved mechanisms are unclear."1.38Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. ( Lin, C; McKee, C; Morgan, M; Mouralidarane, A; Oben, JA; Roskams, T; Soeda, J, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soeda, J1
Morgan, M1
McKee, C1
Mouralidarane, A1
Lin, C1
Roskams, T1
Oben, JA1

Other Studies

1 other study available for mecamylamine and Liver Cirrhosis

ArticleYear
Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells.
    Biochemical and biophysical research communications, 2012, Jan-06, Volume: 417, Issue:1

    Topics: Cell Proliferation; Cells, Cultured; Collagen; Gene Expression; Hepatic Stellate Cells; Humans; Live

2012